MedPath
HSA Approval

CEFTRIAXONE-AFT POWDER FOR INJECTION 0.5G/VIAL

SIN15207P

CEFTRIAXONE-AFT POWDER FOR INJECTION 0.5G/VIAL

CEFTRIAXONE-AFT POWDER FOR INJECTION 0.5G/VIAL

April 11, 2017

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

J01DD04

ceftriaxone

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

Qilu Pharmaceutical Co Ltd

Active Ingredients

CEFTRIAXONE SODIUM 0.540g eqv to CEFTRIAXONE BASE

0.5g/vial

Ceftriaxone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CEFTRIAXONE-AFT POWDER FOR INJECTION 0.5G/VIAL - HSA Approval | MedPath